The Oncology Nursing Foundation is recruiting volunteers to review the 2026 Josh Gottheil Transplantation & Cellular Therapy (TCT) Career Development Award applications. In order to be eligible to review, you must have 3-5 years of experience in stem cell or bone marrow transplant.
The Josh Gottheil TCT Career Development Award is funded by the Josh Gottheil Memorial Fund for Lymphoma Research. It was established by Dr. Fred Gottheil, Dr. Diane Gottheil, and Lisa Gottheil in memory of their son and brother, Josh, who died from lymphoma in 1989.
The award supports non-advanced practice-level registered nurses working in stem cell and bone marrow transplantation by providing financial assistance up to $2,000 to attend either a virtual or in-person nursing continuing professional development specific to transplant nursing that will further the nurses’ professional goals as they relate to transplant nursing.
Below is the application timeline for the Josh Gottheil SCT/BMT Career Development Award:
Application Opens – February 15, 2026
Applications Due - June 19, 2026
Volunteers are asked to apply by June 15, 2026. Eligible volunteers for this review will be notified by June 16, 2026.
TIME COMMITMENT:
The Josh Gottheil TCT Career Development Award review period allows reviewers a little over three weeks to complete their assignments (final review scores will be due on July 11, 2025).
Review Begins – Monday, June 22nd, 2026
Review Scores Due – Wednesday, July 15th (final scores due by 11:59pm Eastern Time)
Each reviewer will be assigned 3-5 applications, which can take from 10-15 minutes each to complete. The overall time commitment anticipated for this review is approximately 3.5 hours.
APPLY:
ONS members who have 3-5 years’ experience in stem cell or bone marrow transplantation are invited to apply by logging into the ONS Communities and clicking the "Apply Now" button at the top of this page. Applications to participate in this review are due June 15th, 2026.
EXPERIENCE REQUIRED:
Must have 3-5 years’ experience in stem cell or bone marrow transplantation.